Literature DB >> 24331588

Effects of octreotide on nitric oxide synthase expression in the small intestine of high fat diet-induced obese rats.

Yan Ou1, Rui Liu2, Na Wei1, Xian Li3, Ou Qiang3, Wei Huang1, Chengwei Tang1.   

Abstract

OBJECTIVE: To investigate whether obesity induced by high fat diet is associated with expression of neuronal, endothelial, and inducible nitric oxide synthase (nNOS, eNOS, and iNOS) in the intestine, and to test the effects of the somatostatin analog octreotide on this expression.
METHODS: The study included high fat diet-induced obese and normal control rats. The obese rats were further separated into an obese control group and an octreotide intervention group. Rats in the intervention group were injected with 40 μg/kg octreotide every 12 h for 8 days. Expressions of nNOS, eNOS, and iNOS in the small intestine were analyzed by RT-PCR and immunohistochemistry. The NO level of small intestinal homogenate was measured with an ELISA kit.
RESULTS: The body weight; Lee's index; small intestinal eNOS and iNOS mRNA and protein expression levels; nNOS protein expression levels; and small intestinal homogenate NO levels were all significantly higher in the obese control group than in the normal controls (p < 0.01); nNOS mRNA expression was also higher in the obese control group, but not significantly so. Octreotide intervention significantly reduced the body weight and small intestinal homogenate NO level of the obese rats relative to the obese control group (p < 0.05). The mRNA and protein expression levels of eNOS and iNOS; the protein expression level of nNOS in the small intestine were also significantly lower in the octreotide intervention group than in the obese control group (p < 0.01), while nNOS mRNA expression was lower but not significantly so.
CONCLUSION: High fat diet-induced obesity is associated with elevated small intestinal nNOS, eNOS, and iNOS expression levels. Octreotide treatment can inhibit nNOS, eNOS, and iNOS expression and lead to weight loss. Â
© 2012 Asian Oceanian Association for the Study of Obesity . Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 24331588     DOI: 10.1016/j.orcp.2011.11.004

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  5 in total

1.  Inducible nitric oxide synthase-derived nitric oxide reduces vagal satiety signalling in obese mice.

Authors:  Yang Yu; Sung Jin Park; Michael J Beyak
Journal:  J Physiol       Date:  2018-12-18       Impact factor: 5.182

2.  NO regulation of gut-brain signalling in obesity.

Authors:  Amanda J Page
Journal:  J Physiol       Date:  2019-01-16       Impact factor: 5.182

3.  Bioengineered in vitro enteric nervous system.

Authors:  Eleana Manousiouthakis; Ying Chen; Dana M Cairns; Rachel Pollard; Kaia Gerlovin; Michael J Dente; Yasmin Razavi; David L Kaplan
Journal:  J Tissue Eng Regen Med       Date:  2019-07-22       Impact factor: 3.963

4.  Octreotide ameliorates inflammation and apoptosis in acute and kindled murine PTZ paradigms.

Authors:  M Y Al-Shorbagy; Noha N Nassar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-10-01       Impact factor: 3.000

5.  Unhealthy Diets Induce Distinct and Regional Effects on Intestinal Inflammatory Signalling Pathways and Long-Lasting Metabolic Dysfunction in Rats.

Authors:  Sofia Nogueira; Joana Barbosa; Juliana Faria; Susana I Sá; Armando Cardoso; Raquel Soares; Bruno M Fonseca; Sandra Leal
Journal:  Int J Mol Sci       Date:  2022-09-19       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.